MicrobiologybioRxivPreprint
Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2
S. Rajasekharan, R. Milan Bonotto, Y. Kazungu…·A. Marcello
This study shows that Miglustat inhibits SARS-CoV-2 by targeting glucosidases, reducing viral proteins and infectious virus release at clinically achievable concentrations.
DOI 10.1101/2020.05.18.101691